Tag: Akura Medical
Akura Medical enrols first patient in QUADRA-PE study
Akura Medical has announced today the first patient enrolment in the QUADRA-PE study evaluating the Katana thrombectomy system in patients with acute pulmonary embolism...
US FDA approves IDE application for Katana thrombectomy system
The US Food and Drug Administration (FDA) has approved Akura Medical’s investigational device exemption (IDE) application to initiate the QUADRA-PE study evaluating the Katana...
Akura Medical closes US$25M Series A1 funding round
Akura Medical has announced the closing of its $25M Series A1 financing, which will be used to support the development of its next-generation thrombectomy device.
The financing...